Fast-Growing Oncology Startup OncoLens Secures $7.25 Million Series A Funding
OncoLens, a pioneer in tumor board and cancer treatment planning solutions, announced today that it has raised a $7.25 million Series A investment from BIP Capital, Martin Ventures, and SeedToB…
Read More